The contract pharmaceutical development and manufacturing company has appointed Mikael Ericson as new CEO.
According to a statement from Kemwell Mikael Ericson is highly experienced in production, logistics and lean management and has held various international management positions in large corporations in both pharmaceutical and
automotive industries, such as AstraZeneca, Scania and Plastal Industri.
“With his in-depth technical and business background, Mikael will be an excellent leader for taking the company to the next level together along with Kemwell’s experienced associates,” said the Chairman of the Board, PerÅke Oldentoft.
Ericson assumed responsibilities on 1st of September, 2014 and will succeed Agneta Bergvall.